Patient-reported Outcome Claims On Kepivance Site Gets Full Throated FDA Response
This article was originally published in The Pink Sheet Daily
Executive Summary
SOBi’s oral mucositis treatment was studied in controlled trials that used patient-reported outcome measures, but their content validity has not been established, FDA’s Office of Prescription Drug Promotion says.